Ligand Pharma (LGND) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $312.01 -1.29%
Revenue Growth %: +32.4%
Financial Fact:
Total revenues: 21.62M
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +32.4%
Financial Fact:
Total revenues: 21.62M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $0.62, $0.03 better than the analyst estimate of $0.59. Revenue for the quarter came in at $21.6 million versus the consensus estimate of $23.13 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump discloses over $1.4 billion in crypto income in 2025 filing
- NHC acquires 35 facilities from NHI for $560 million
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
